Asset 2Asset 2Asset 2Asset 2
  • Capabilities
    • Trial Design and Management
    • Data Management
    • Regulatory and Quality
    • Consulting and Program Management
    • Biospecimens and Logistics
  • Expertise
    • Trial Types
    • Health Innovation Solutions
    • Clinical Applications
  • About Us
    • Company
    • Management Team
  • News & Events
  • Contact
✕
            No results See all results
            • Filter by
            • Categories
            • Tags
            • Authors
            • Show all
            • All
            • Events
            • GBC Blog
            • In Vitro Diagnostics - IVD News
            • Press Releases
            • All
            • All
            • neil.mucci@globalbioclinical.com
            July 8, 2020
            Published by admin on July 8, 2020
            Categories
            • GBC Blog

            Could a Blood ‘Observatory’ Stop Pandemics?

            By Robert Bazell – Science 26 Jun 2020: Vol. 368, Issue 6498, pp. 1413. Michael Mina is out for blood—millions of samples, which a nascent effort […]
            Do you like it?0
            Read more
            June 1, 2020
            Published by admin on June 1, 2020
            Categories
            • GBC Blog

            BioGX and Bosch Healthcare Solutions Announce Partnership to Develop Infectious Disease Tests for the Vivalytic Platform

            BIRMINGHAM, Ala. and STUTTGART, Germany, May 26, 2020 /PRNewswire/ — BioGX and Bosch Healthcare Solutions have partnered to develop point-of-care infectious disease tests for the Bosch […]
            Do you like it?0
            Read more
            May 18, 2020
            Published by admin on May 18, 2020
            Categories
            • GBC Blog

            F.D.A. Clears Everlywell Coronavirus Testing Kit for Use at Home

            The agency granted emergency clearance for a testing kit that allows a consumer to take a nasal sample at home and send it to a laboratory […]
            Do you like it?0
            Read more
            May 18, 2020
            Published by admin on May 18, 2020
            Categories
            • GBC Blog

            Gates-Backed At-Home COVID-19 Testing Program

            (Reuters) – An at-home coronavirus testing project in Seattle backed in part by the Bill and Melinda Gates Foundation said on Saturday it was working with […]
            Do you like it?0
            Read more
            May 18, 2020
            Published by admin on May 18, 2020
            Categories
            • GBC Blog

            Fluxergy Announces $30 Million to Expand Manufacturing Capacity of Its One-hour Point-of-care Diagnostic Testing System in Response to COVID-19

            IRVINE, California, May 13, 2020 /PRNewswire/ — Irvine, California-based Fluxergy LLC, a diagnostic test company, is making a $30 million investment to expand its capability to scale production of the Fluxergy Analyzer […]
            Do you like it?0
            Read more
            May 8, 2020
            Published by admin on May 8, 2020
            Categories
            • GBC Blog

            FDA Grants Emergency Use Authorization for Rutgers’ At-Home COVID-19 Saliva Test

            Published: May 08, 2020 By Alex Keown Rutgers’ RUCDR Infinite Biologics received an amended Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) for the first SARS-CoV-2 coronavirus test that […]
            Do you like it?0
            Read more
            May 8, 2020
            Published by admin on May 8, 2020
            Categories
            • GBC Blog

            Profile of a Killer: The Complex Biology Powering the Coronavirus Pandemic

            Scientists are piecing together how SARS-CoV-2 operates, where it came from and what it might do next — but pressing questions remain about the source of […]
            Do you like it?0
            Read more
            April 23, 2020
            Published by admin on April 23, 2020
            Categories
            • GBC Blog

            Vela Diagnostics Coronavirus RT-PCR Test Provisionally Authorized by Singapore Regulator

            Vela Diagnostics said on Thursday it has received provisional authorization from Singapore’s Health Sciences Authority for the firm’s ViroKey SARS-CoV-2 RT-PCR Test. As a result, Vela […]
            Do you like it?0
            Read more
            April 13, 2020
            Published by admin on April 13, 2020
            Categories
            • GBC Blog

            Bosch Develops Rapid Test To Combat Coronavirus Infections

            07-APR-2020. German engineering and technology company Bosch has said its rapid test can detect a SARS-CoV-2 coronavirus infection in patients within two-and-a-half hours. Developed in just […]
            Do you like it?0
            Read more
            Prev page
            123456789101112131415161718192021
            Next page

            Global BioClinical
            600 1st Avenue, Suite 330 PMB 80042
            Seattle, WA 98104-2246 USA

            Tel: +1 888 659 1221
            Fax: +1 206 299 9895
            Email: info@globalbioclinical.com

            Capabilities

            Trial Design and Management

            Data Management

            Regulatory and Quality

            Consulting and Program Management

            Biospecimens and Logistics

            Expertise

            Trial Types

            Health Innovation Solutions

            Clinical Applications

            About Us

            Company

            Management Team

            News & Events

            Contact

            © 2025 Global BioClinical. All rights reserved. | Privacy Policy

                      No results See all results
                      ✕